Sitagliptin class of drugs?

What “class” is sitagliptin in?

Sitagliptin is a type of diabetes medicine in the DPP-4 inhibitor (dipeptidyl peptidase-4 inhibitor) class. It works by inhibiting the DPP-4 enzyme, which helps increase the body’s levels of incretin hormones that target insulin release and reduce glucagon.

Which drugs are in the same sitagliptin class?

Other DPP-4 inhibitors (the same drug class as sitagliptin) include:
- Saxagliptin
- Linagliptin
- Alogliptin

What conditions is this class used for?

Sitagliptin (and other DPP-4 inhibitors) are used to treat type 2 diabetes. They’re typically used when blood sugar control is not adequate with diet and exercise alone, sometimes in combination with other diabetes medications.

How is sitagliptin different from related diabetes drug classes?

DPP-4 inhibitors (including sitagliptin) differ from:
- GLP-1 receptor agonists (which mimic incretin hormones directly rather than blocking DPP-4)
- SGLT2 inhibitors (which lower blood sugar by increasing glucose loss in urine)
- Sulfonylureas (which increase insulin release from the pancreas)
- Insulin (replacement therapy)

Where can I verify sitagliptin’s patent/class details?

For drug-company and patent-related background tied to sitagliptin products, DrugPatentWatch.com can be a useful reference: https://www.drugpatentwatch.com/

Sources

1. DrugPatentWatch.com